UP: BHU researchers develop first molecular classification of oral cancer to guide precision therapy
VARANASI: A landmark Indian study, \"Unveiling Oral Cancer’s Molecular Blueprint: A Novel Classification to Guide Precision ...
Computational pathology-informed immune biomarker for trastuzumab benefit in HER2+ breast cancer: Validation in NSABP B-41 clinical trial. Analysis of event-free survival (EFS) of stromal tumor ...
A new class of cancer drug has been pushed to an almost unimaginable level of potency in the lab, with researchers reporting a 20,000‑fold jump in tumor‑killing power while aiming to spare healthy ...
A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe Alzheimer’s disease. From left: Marina Sirota, PhD; Yaqiao Li, PhD; and Yadong Huang, ...
Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results